1
|
Espino A, Vargas JI, Mancilla C, Muñoz P, Martínez W, Menéndez A, Jara D, Mansilla R, Schiappacasse G, Santamarina M, Huete Á, Candia R, Silva F, Castillo C, Richter H, Mejía R, Vial P, Robles I, Martínez J, Jarufe N, Briceño E, Lembach H, Zoroquiain P, Roa JC, Walker K, Torres J, Carreño L, Castiblanco A, Fernández W, Ríos Á, Chandia J, Ayala MJ, Rojas T, Verdugo J, Berger Z. [Chilean consensus on diagnosis and management of pancreatic cystic neoplasms]. Rev Med Chil 2021; 149:1773-1786. [PMID: 35735345 DOI: 10.4067/s0034-98872021001201773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Accepted: 12/15/2021] [Indexed: 12/29/2022]
Abstract
Pancreatic cystic neoplasms (PCN) are frequently detected on abdominal images performed for non-pancreatic indications. Their prevalence in asymptomatic population ranges from 2.7 to 24.8%, and increases with age. There are several types of pancreatic cysts. Some may contain cancer or have malignant potential, such as mucinous cystic neoplasms, including mucinous cystadenoma (MCN) and intraductal papillary mucinous neoplasms (IPMN). In contrast, others are benign, such as serous cystadenoma (SCA). However, even those cysts with malignant potential rarely progress to cancer. Currently, the only treatment for pancreatic cysts is surgery, which is associated with high morbidity and occasional mortality. The Board of the Chilean Pancreas Club of the Chilean Gastroenterology Society developed the first Chilean multidisciplinary consensus for diagnosis, management, and surveillance of PCN. Thirty experts were invited and answered 21 statements with five possible alternatives: 1) fully agree; 2) partially agree; 3) undecided; 4) disagree and 5) strongly disagree. A consensus was adopted when at least 80% of the sum of the answers "fully agree" and "partially agree" was reached. The consensus was approved by the Board of Directors of the Chilean Pancreas Club for publication.
Collapse
Affiliation(s)
- Alberto Espino
- Departamento de Gastroenterología, Hospital Clínico UC-Christus, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - José Ignacio Vargas
- Departamento de Gastroenterología, Hospital Clínico UC-Christus, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Carla Mancilla
- Departamento de Medicina, Hospital Clínico, Universidad de Chile, Santiago, Chile
| | - Pablo Muñoz
- Departamento de Medicina, Hospital Clínico, Universidad de Chile, Santiago, Chile
| | - Waldo Martínez
- Cirugía Digestiva, Clínica Colonial, Huechuraba, Santiago, Chile
| | | | | | - Rodrigo Mansilla
- Facultad de Medicina y Ciencia, Universidad San Sebastián, Puerto Montt, Chile
| | - Giancarlo Schiappacasse
- Departamento de Radiología, Facultad de Medicina, Universidad de Desarrollo, Santiago, Chile
| | - Mario Santamarina
- Departamento de Radiología, Hospital Naval Almirante Nef, Viña del Mar, Valparaíso, Chile
| | - Álvaro Huete
- Departamento de Radiología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Roberto Candia
- Departamento de Gastroenterología, Hospital Clínico UC-Christus, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Felipe Silva
- Hospital Regional de Coyhaique, Coyhaique, Chile
| | - Cecilia Castillo
- Cirugía Endoscópica, Hospital Clínico San Borja Arriarán; Endoscopía, Clínica Alemana de Santiago, Santiago, Chile
| | - Hugo Richter
- Departamento de Cirugía Digestiva, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Ricardo Mejía
- Departamento de Cirugía Digestiva, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Paula Vial
- Departamento de Gastroenterología, Clínica Alemana de Santiago, Santiago, Chile
| | | | - Jorge Martínez
- Departamento de Cirugía Digestiva, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Peña C, González JT, López-Vidal H, Donoso J, Contreras C, Vergara CG, Hojas R, Soto P, Correa G, Valjalo R, Ríos Á, Larrondo J, Álvarez J, Rojas C. AL amyloidosis in the Chilean public health system: a pending debt. Multicenter study of the Chilean Monoclonal Gammopathies Cooperative Group. Rev Med Chil 2020; 147:1239-1246. [PMID: 32186631 DOI: 10.4067/s0034-98872019001001239] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2019] [Accepted: 08/21/2019] [Indexed: 11/17/2022]
Abstract
BACKGROUND Immunoglobulin light chain (AL) amyloidosis is a rare and underdiagnosed entity. AIM To characterize patients with AL amyloidosis in Chilean public health centers. MATERIAL AND METHODS We conducted a retrospective, multicenter study. Public centers of the Chilean Monoclonal Gammopathies Cooperative Group were asked to search for patients with AL amyloidosis in their databases. Epidemiological, clinical and laboratory characteristics were evaluated. RESULTS Forty-two patients aged 22 to 84 years were found. Twenty four percent had localized AL amyloidosis; 64% had a lambda light chain clone; 47% were associated with multiple myeloma and 9% with non-Hodgkin lymphoma. The most commonly involved organ was the kidney (76%). Serum free light chains were measured in 31% and an echocardiogram was performed in 74% of patients. Seventeen percent of patients received only palliative care, 17% were treated with bortezomib, 21% with thalidomide, and 40% with melphalan. No patient was transplanted. The mean overall survival (OS) of the group was 19 months. The 5-year OS was 28%. CONCLUSIONS It is important to obtain these realistic, national data to initiate strategies to improve early diagnosis and proper management of this disease.
Collapse
Affiliation(s)
- Camila Peña
- Hematology Section, Hospital del Salvador, Santiago, Chile
| | | | | | - Javiera Donoso
- Hematology Section, Hospital Sótero del Río, Santiago, Chile
| | | | | | - Ricardo Hojas
- Hematology Section, San Borja Arriarán, Santiago, Chile
| | - Pablo Soto
- Hematology Section, Hospital base de Puerto Montt, Puerto Montt, Chile
| | - Gonzalo Correa
- Nephrology Section, Hospital del Salvador, Santiago, Chile
| | | | - Álvaro Ríos
- Nephrology Section, Hospital del Salvador, Santiago, Chile
| | - Jorge Larrondo
- Dermatoloy Section, Hospital del Salvador, Santiago, Chile
| | - Jaime Álvarez
- Cardiology Section, Hospital del Salvador, Santiago, Chile
| | - Christine Rojas
- Hematology Section, Hospital Gustavo Fricke, Viña del Mar, Chile
| |
Collapse
|
3
|
Azzaoui K, Mejdoubi E, Lamhamdi A, Jodeh S, Hamed O, Berrabah M, Jerdioui S, Salghi R, Akartasse N, Errich A, Ríos Á, Zougagh M. Preparation and characterization of biodegradable nanocomposites derived from carboxymethyl cellulose and hydroxyapatite. Carbohydr Polym 2017; 167:59-69. [DOI: 10.1016/j.carbpol.2017.02.092] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2016] [Revised: 02/18/2017] [Accepted: 02/22/2017] [Indexed: 10/20/2022]
|
4
|
Ríos Á, Herrera P, Morales Á, Reynolds E, Fernández MB, González F. [Survival of older patients starting hemodialysis in Chile]. Rev Med Chil 2016; 144:697-703. [PMID: 27598487 DOI: 10.4067/s0034-98872016000600002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2015] [Accepted: 04/06/2016] [Indexed: 11/17/2022]
Abstract
UNLABELLED The proportion of older people with end stage renal disease is increasing. Their prognosis is characterized by a high mortality and poor quality of life. AIM To analyze the survival of patients starting chronic hemodialysis (CHD) according to their age. MATERIAL AND METHODS Patients admitted to CHD in the East Metropolitan Health Service of Santiago in a 2-year period were analyzed. Four age groups were created, separating patients older than 70 years in a special group. RESULTS During the study period, 459 patients were admitted to CHD and were followed for an average of 27 months. The frequency of cardiovascular comorbidity, cancer, and chronic renal disease of unknown cause (attributed to nephrosclerosis) increased along with age. Mortality was higher at older ages. There was a significant association between starting CHD with a catheter, Charlson comorbidity index and increasing age with mortality. For those aged over 80 years, mortality at three months and one year was 25 and 43% respectively. CONCLUSIONS Age, Charlson index and vascular access are predictors of mortality in older adults entering hemodialysis. This study suggests the importance of considering comorbidities, assessment by specialists and creating an arteriovenous fistula in this age group.
Collapse
Affiliation(s)
- Álvaro Ríos
- Sección de Nefrología, Servicio de Medicina, Hospital del Salvador, Santiago, Chile,
| | - Patricia Herrera
- Sección de Nefrología, Servicio de Medicina, Hospital del Salvador, Santiago, Chile
| | - Álvaro Morales
- Departamento de Medicina Oriente, Universidad de Chile, Santiago, Chile
| | - Enrique Reynolds
- Sección de Nefrología, Servicio de Medicina, Hospital del Salvador, Santiago, Chile
| | | | - Fernando González
- Departamento de Medicina Oriente, Universidad de Chile, Santiago, Chile
| |
Collapse
|
5
|
Sampériz G, Guerrero D, López M, Valera JL, Iglesias A, Ríos Á, Campins A, Sala E, Murillas J, Togores B, Palmer J, Rodriguez M, Soriano JB, Sauleda J, Riera M, Agusti A. Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy. HIV Med 2013; 15:321-9. [DOI: 10.1111/hiv.12117] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/22/2013] [Indexed: 11/30/2022]
Affiliation(s)
- G Sampériz
- Fundación de investigación Sanitaria de las Islas Baleares Ramon Llull (FISIB); Palma de Mallorca Spain
- Son Espases University Hospital; Palma de Mallorca Spain
| | - D Guerrero
- Fundación de investigación Sanitaria de las Islas Baleares Ramon Llull (FISIB); Palma de Mallorca Spain
| | - M López
- Fundación de investigación Sanitaria de las Islas Baleares Ramon Llull (FISIB); Palma de Mallorca Spain
| | - JL Valera
- Son Espases University Hospital; Palma de Mallorca Spain
| | - A Iglesias
- Respiratory diseases CIBERs (CIBERES); Palma de Mallorca Spain
| | - Á Ríos
- Fundación de investigación Sanitaria de las Islas Baleares Ramon Llull (FISIB); Palma de Mallorca Spain
| | - A Campins
- Son Espases University Hospital; Palma de Mallorca Spain
| | - E Sala
- Fundación de investigación Sanitaria de las Islas Baleares Ramon Llull (FISIB); Palma de Mallorca Spain
- Son Espases University Hospital; Palma de Mallorca Spain
- Respiratory diseases CIBERs (CIBERES); Palma de Mallorca Spain
| | - J Murillas
- Son Espases University Hospital; Palma de Mallorca Spain
| | - B Togores
- Fundación de investigación Sanitaria de las Islas Baleares Ramon Llull (FISIB); Palma de Mallorca Spain
- Son Espases University Hospital; Palma de Mallorca Spain
- Respiratory diseases CIBERs (CIBERES); Palma de Mallorca Spain
| | - J Palmer
- Son Espases University Hospital; Palma de Mallorca Spain
| | - M Rodriguez
- Son Espases University Hospital; Palma de Mallorca Spain
| | - JB Soriano
- Fundación de investigación Sanitaria de las Islas Baleares Ramon Llull (FISIB); Palma de Mallorca Spain
| | - J Sauleda
- Fundación de investigación Sanitaria de las Islas Baleares Ramon Llull (FISIB); Palma de Mallorca Spain
- Son Espases University Hospital; Palma de Mallorca Spain
- Respiratory diseases CIBERs (CIBERES); Palma de Mallorca Spain
| | - M Riera
- Son Espases University Hospital; Palma de Mallorca Spain
| | - A Agusti
- Fundación de investigación Sanitaria de las Islas Baleares Ramon Llull (FISIB); Palma de Mallorca Spain
- Respiratory diseases CIBERs (CIBERES); Palma de Mallorca Spain
- Thorax Institute; Hospital Clinic; Institute of Biomedical Research August Pi i Sunyer (INDIBAPS); Barcelona Spain
- University of Barcelona; Barcelona Spain
| |
Collapse
|